l e t t e r S Intra-abdominal tumors, such as ovarian cancer 1, 2 , have a clear predilection for metastasis to the omentum, an organ primarily composed of adipocytes. Currently, it is unclear why tumor cells preferentially home to and proliferate in the omentum, yet omental metastases typically represent the largest tumor in the abdominal cavities of women with ovarian cancer. We show here that primary human omental adipocytes promote homing, migration and invasion of ovarian cancer cells, and that adipokines including interleukin-8 (IL-8) mediate these activities. Adipocyte-ovarian cancer cell coculture led to the direct transfer of lipids from adipocytes to ovarian cancer cells and promoted in vitro and in vivo tumor growth. Furthermore, coculture induced lipolysis in adipocytes and β-oxidation in cancer cells, suggesting adipocytes act as an energy source for the cancer cells. A protein array identified upregulation of fatty acid-binding protein 4 (FABP4, also known as aP2) in omental metastases as compared to primary ovarian tumors, and FABP4 expression was detected in ovarian cancer cells at the adipocyte-tumor cell interface. FABP4 deficiency substantially impaired metastatic tumor growth in mice, indicating that FABP4 has a key role in ovarian cancer metastasis. These data indicate adipocytes provide fatty acids for rapid tumor growth, identifying lipid metabolism and transport as new targets for the treatment of cancers where adipocytes are a major component of the microenvironment.
Most ovarian cancers are diagnosed at an advanced stage when the tumor is widely metastatic 1, 2 . The most common subtype is serous ovarian cancer, which may arise from the surface of the ovary or, as recently suggested, the fimbriated end of the fallopian tube 3 . The main site of ovarian cancer metastasis is the omentum, and 80% of all women with serous ovarian carcinoma present with omental meta stases. The omentum, a large (20 × 12 × 3 cm) fat pad that extends from the stomach and covers the bowel (Supplementary Fig. 1a) , func tions as an endocrine organ and storage site for energydense lipids 4 . Ovarian cancer metastasis to the omentum results in transformation of this soft pad of tissue, primarily composed of adipocytes, to a solid tumor histologically devoid of adipocytes ( Supplementary Fig. 1b and Fig. 1a) . If metastasis was a random event, all organs in contact with peritoneal fluid would have an equal distribution of metastases. However, both primary and recurrent highgrade serous ovarian carcinomas preferentially metastasize to adipose tissue. The molecular mechanisms underlying this predilection are unknown. Recognizing the importance of the microenvironment, we considered the possibil ity that adipocytes contribute to the metastatic cascade.
Ovarian cancer metastasis can be mimicked in female athymic nude mice by injecting fluorescentlylabeled SKOV3ip1 human ovarian cancer cells intraperitoneally. After 20 min, a majority of tumor cells homed to the omentum (Fig. 1b) . Because most cells in the omentum are adipocytes, we determined whether purified, viable adipocytes 5 from normal human omentum (Supplementary Fig. 2a ) promoted the early steps of ovarian cancer metastasis, migration and invasion. SKOV3ip1 human ovarian cancer cells were placed in the top compartment of a Boyden chamber and adipocytes or conditioned medium from adipo cytes in the bottom. Human omental adipocytes induced migration of SKOV3ip1 cells. Because the addition of omental adipocyteconditioned medium had a greater effect on migration than the addition of omen tal adipocytes, we suspected this effect was mediated by soluble factors (Fig. 1c) . Invasion was more potently stimulated by omental adipocytes than adipocytecontained medium (Fig. 1d) . Comparing omental with subcutaneous adipocytes, we found that omental adipocytes were sig nificantly more efficient in promoting invasion of ovarian cancer cells (Fig. 1e) . In addition, invasion was promoted by omental adipocytes in gastric, breast and colon cancer cells (Supplementary Fig. 2b ). In con trast, neither nontransformed human ovarian surface epithelial cells nor primary omental fibroblasts invaded in the presence of adipocytes.
To identify factors responsible for attracting ovarian cancer cells to the omentum, we performed a cytokine array (Fig. 1f) . Among 62 cytokines tested, the five cytokines most abundantly secreted by omental adipocytes were IL6, IL8, monocyte chemoattractant protein1 (MCP1), tissue inhibitor of metalloproteinases1 (TIMP1) and adiponectin. Antibodymediated inhibition of IL6, IL8, MCP1
and TIMP1 resulted in a reduction of in vitro ovarian cancer cell homing toward adipocytes by at least 50% (Fig. 1g) . Inhibition of IL6 and IL8 receptors (IL6R and IL8R), as well as their ligands, IL6 and IL8, using neutralizing antibodies 6,7 reduced adhesion of SKOV3ip1 cells to sections of human omentum and migration toward primary human omental adipocytes in vitro ( Fig. 1h and Supplementary Fig. 3a) . A neutralizing antibody against the IL 8R (CXCR1) reduced in vivo homing of ovarian cancer cells to the mouse omentum more efficiently than the IL6R-specific inhibitory antibody (Supplementary Fig. 3b) . Notably, CXCR1 expression was strongly upregulated in ovarian cancer cells, whereas the expression of IL6R or its accessory protein, glycoprotein 130 (gp130), remained unchanged after cocultivation with adipocytes ( Supplementary  Fig. 3c,d) . Congruently, mitogenic signaling was induced in ovarian cancer cell adipocytes (ref. 6) through p38 mitogenactivated protein kinase and signal transducer and activator of transcription 3 phos phorylation (Fig. 1i) . Activation of p38 was partially reversed by a CXCR1neutralizing antibody (Supplementary Fig. 3e ). These data indicated that adipocytes promote the early steps of ovarian cancer metastasis to the omentum, although a mechanistic explanation for the prevalence of omental metastatic tumors in women with ovarian cancer remained elusive.
Adipocytes promote the growth of cancer cells [8] [9] [10] . Because adi pocytes comprise a majority of the omentum and store triglycerides, we hypothesized that adipocytes provide energydense lipids to ovarian cancer cells to support rapid growth. Remarkably, in tissue from women with omental metastasis, the ovarian cancer cells at the adipocyte-cancer cell interface contained abundant lipids ( Fig. 2a and Supplementary Fig. 4) . Notably, coculture of ovarian, breast or colon cancer cells with adipocytes resulted in cytoplasmic lipid droplet accumulation in the cancer cells ( Fig. 2b and Supplementary  Fig. 5a ), which we confirmed by transmission electron microscopy ( Fig. 2c) . Coculture with omental or peritoneal adipocytes led to the greatest lipid accumulation in ovarian cancer cells compared to cocultures with subcutaneous or bowel mesenteric adipocytes (Supplementary Fig. 5b ).
To determine whether the lipids detected in cancer cells after coculture were derived from adipocytes and not de novo lipogenesis, we cultured cancer cells with adipocytes that had been loaded with fluorescently labeled lipids. During coculture, fluorescent lipids were transferred from adipocytes to SKOV3ip1 cells (Fig. 2d) , support ing a model in which adipocytes provide lipids to support tumor growth. Consistent with these results, the coculture of three different ovarian cancer cell lines, including the recently established primary ovarian cancer cell line, MONTY1 (ref. 11), with adipocytes led to a significant increase in cancer cell proliferation in vitro ( Fig. 2e and Supplementary Fig. 5c ). In vivo, subcutaneous injection of SKOV3ip1 cells with primary human omental adipocytes into the flanks of nude mice produced tumors that were, on average, three times larger than tumors produced by SKOV3ip1 cells alone 12 (Fig. 2f) .
Our results indicated that adipocytes provide a proliferative advan tage and transfer fatty acids to ovarian cancer cells (Fig. 2) . Thus, we suspected that the interaction between adipocytes and ovarian cancer cells results in metabolic alterations in both cell types. The interaction between adipose tissue and contracting muscle supplies an analogous physiological model for the interaction between ovarian l e t t e r S cancer cells and adipocytes. The energy for contracting muscle is provided by fatty acids mobilized from adipocytes 13 . The transport of free fatty acids depends on the lipolysis of stored triglycerides to free fatty acids and glycerol. Lipolytic activation in adipocytes com monly results from βadrenergic receptor stimulation 14 . Subsequently, receptor activation elicits a G protein-coupled cascade and ultimately phosphorylation of hormonesensitive lipase (HSL) and perilipin A, the ratelimiting enzymes in triglyceride hydrolysis 15 and the lipid droplet gatekeeper 16 , respectively. To understand the effect ovarian cancer cells have on adipocytes, we assessed adipocyte metabolism. In the presence of ovarian cancer cells, adipocytes released significantly more free fatty acids and glycerol 17 than adipocytes cultured alone (Fig. 3a,b) . Perilipin mRNA levels (Supplementary Fig. 6a ) and HSL phosphorylation (Fig. 3c,d) were also induced in primary human omental adipocytes. Furthermore, propranolol, the βadrenergic receptor antagonist, partially reversed ovarian cancer cell-induced HSL activation (Supplementary Fig. 6b ). Taken together, these find ings suggest cancer cells induce adipocyte lipolysis. Next, we evaluated metabolic alterations in ovarian cancer cells after coculture with adipocytes. AMPactivated protein kinase (AMPK) is a central metabolic sensor that, upon phosphorylation, favors energy producing processes by inhibiting lipogenesis and activating βoxidation 18 . This metabolic switch is regulated by the phosphoryla tion of acetylCoA carboxylase (ACC). Phosphorylation of ACC by AMPK or, to a lesser extent, protein kinase A 19 results in its inactiva tion and inability to inhibit carnitine palmitoyltransferase 1 (CPT1). CPT1 is the ratelimiting enzyme regulating mitochondrial import of fatty acids for βoxidation in the form of acylCoA. Coculture of SKOV3ip1 cells with human omental adipocytes increased the phosphorylation of AMPK (Fig. 3e,f) , the activity of protein kinase A (Supplementary Fig. 6c ) and the rate of βoxidation (Fig. 3g and  Supplementary Fig. 6d ) in ovarian cancer cells. This was paralleled by an increase in mRNA levels of CPT1 and acylCoA oxidase 1, the first enzyme in the βoxidation pathway (Fig. 3h) . These data suggest that adaptation of lipid metabolism allows ovarian cancer cells to thrive on lipids acquired from adipocytes.
In an effort to understand molecular differences induced by omental adipocytes, we compared primary ovarian cancer tissue and omental metastatic tissue from 22 women with advanced serous carcinoma using a reversephase protein array 20 . Of note, seven of the ten most upregulated or activated proteins in the omental metastases (Supplementary Fig. 7a ) were known regulators of cancer cell growth (retinoblastoma protein, mammalian target of rapamycin and signal transducer and activator of transcription 5) and metabolism (phos phoinositide 3kinase, total and phosphorylated ACC, and FABP4). The array showed that total and phosphorylated ACC amounts were significantly higher in omental metastases as compared to the primary tumor, which is consistent with an inhibition of lipogenesis in a lipid rich omental environment (Supplementary Fig. 7a-c) .
The protein with the third largest change in expression between primary tumors and metastases was FABP4. FABP4 reversibly binds longchain fatty acids and is highly expressed in adipocytes 21, 22 . In primary ovarian tumors, FABP4 expression was low; however, we found upregulation of FABP4 expression in all omental metastases, which we validated by immunoblotting (Supplementary Fig. 7a,d,e) . Immunohistochemical staining comparing primary ovarian tumor and corresponding omental metastatic tissues in twenty additional pairs revealed that FABP4 was strongly expressed in ovarian cancer cells at the adipocytecancer cell interface (Fig. 4a) . In contrast, we did not detect FABP4 staining in ovarian cancer cells distant from the adipocyte cancer cell interface in omental metastatatic tissue, in tissue from the corresponding primary ovarian tumor or in the adjacent benign ovarian stroma (Fig. 4a) . The upregulation of FABP4 in metastatic human ovar ian cancer samples could be mimicked in vitro; cocultivation of several cancer cell lines (ovarian, breast and colon) with adipocytes induced FABP4 mRNA expression, suggesting this induction is not limited to ovarian cancer cells (Supplementary Fig. 8a ). FABP4 staining of normal tissue from human organs showed FABP4 was expressed in endothelial cells and adipocytes from different ana tomic locations (subcutaneous, peritoneal, mesenteric, omental and cancerassociated omental tissues) independent of the tissue origin ( Supplementary Fig. 8b-d) . FABP4 has been shown to regulate lipol ysis 23 , and its actions can be blocked by smallmolecule inhibitors 24 . When we added a FABP4 inhibitor 25 to the coculture of ovarian cancer cells and adipocytes, lipid accumulation in the cancer cells (Fig. 4b) and adipocytemediated invasion (Fig. 4c) were drastically reduced. However, using the inhibitor did not clarify whether FABP4 expres sion in adipocytes or cancer cells is important for its tumorpromoting functions. Therefore, ovarian cancer tumor growth in aP2knockout (Fabp4 −/− ) mice was assessed. Fabp4 −/− mice have reduced insulin resist ance following environmentally 21 or genetically 26 induced obesity; how ever, the effect of FABP4 deficiency on cancer growth or metastasis has not been determined. After we confirmed the absence or presence of FABP4 mRNA and protein expression in adipose tissue from Fabp4 −/− and wildtype (WT) mice (Supplementary Fig. 9a-c) , we injected ID8 mouse ovarian cancer cells either intraperitoneally or orthotopically under the ovarian bursa. In the intraperitoneal model, we observed a significant reduction in tumor burden in the absence of FABP4 (Fig. 4d) . This was paralleled by a reduction in microvessel density (CD31) and tumor cell proliferation (Ki67), with no change in caspase3 activation in tumors from Fabp4 −/− mice (Supplementary Fig. 9d ), suggesting host FABP4 is important for tumor cell growth without affecting apoptosis. Notably, in the more relevant orthotopic model, when ovarian cancer cells are injected under ovarian bursa, we detected very few metastases in Fabp4 −/− mice (4 ± 2 (Fabp4 −/− ) versus 181 ± 25 (WT) metastatic nodules; Fig. 4e ). To directly test the role of FABP4 in the host adipocytes, we cultured ID8 cells with adipocytes from Fabp4 −/− and WT mice. Lipid content was reduced in ID8 cells cultured with Fabp4 −/− adipocytes as compared to those cultured with WT adipocytes (Fig. 4f ) . These data identify FABP4 as a key mediator of ovarian cancer cell-adipocyte interactions in the host and potentially in the cancer cells by increasing lipid availability and supporting metastasis (Fig. 4g) . Therefore, FABP4 emerges as an excellent target in the treament of intraabdominally dis seminating tumors that preferentially metastasize to adipose tissue, such as ovarian, gastric and colon cancers.
In summary, our findings suggest that adipocytes act as major mediators of ovarian cancer metastasis to the omentum. Adipocytes promote the initial homing of tumor cells to the omentum through adipokine secretion. Subsequently, adipocytes provide fatty acids to the cancer cells, fueling rapid tumor growth. This mechanism may not be limited to ovarian cancer cells and provides a rationale for growth of other malignant cell types that metastasize abdominally or in an adipocyterich environment (for example, in breast tissue). This concept is supported by several recent reports that suggest the l e t t e r S tumor microenvironment promotes growth of breast cancer cells and provides a rationale for the development of targeted therapies that hinder cancer metabolism fueled by the microenvironment 27, 28 . Current research on tumor lipid metabolism focuses primarily on de novo fatty acid synthesis in oncogenetransformed tumor cells via glycolysis and glutaminolysis 29, 30 . However, our work suggests that tumor lipid metabolism is regulated not only by genetic and epi genetic changes in the tumor cells but also by the availability of lipids in the microenvironment. Indeed, lipid metabolism and, more specifi cally, fatty acid metabolism contribute to tumorigenesis [31] [32] [33] [34] . Finally, FABP4, a mediator of lipid trafficking in adipocytes and potentially in tumor cells, may provide a therapeutic target to effectively impede intraabdominal metastasis and growth.
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